Neurotoxicity related to lithium-risperidon combination treatment in a patient with schizoaffective disorder

被引：6

作者：

Boeker, Heinz ^{[1
]}

Brandenberger, Mathias ^{[1
]}

Schopper, Christian ^{[1
]}

机构：

[1] Univ Zurich, Psychiat Klin, CH-8029 Zurich, Switzerland

来源：

PSYCHIATRISCHE PRAXIS | 2007年 / 34卷 / 01期

关键词：

NEUROLEPTIC MALIGNANT SYNDROME; SAFETY;

D O I：

10.1055/s-2005-915352

中图分类号：

R749 [精神病学];

学科分类号：

100205 ;

摘要：

Objective The case of a schizoaffective patient with a neurotoxic encephalopathy related to lithium-risperidon combination treatment is explored. Method A case report and the relevant theoretical and clinical deliberations are described. Conclusions Neurotoxicity related to lithium-risperidon combination treatment is the result of an interaction of different ethiopathogenetic mechanisms. The EEG is the most important diagnostic parameter.

引用

页码：38 / 41

页数：4

共 20 条

[1]

ADITYANJEE, 1989, PHARMACOPSYCHIATRY, V22, P81

[2]

[Anonymous], [No title captured]

[3] Safety and efficacy of combined clozapine-lithium pharmacotherapy [J].

Bender, S ;

Linka, T ;

Wolstein, J ;

Gehendges, S ;

Paulus, HJ ;

Schall, U ;

Gastpar, M .

INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2004, 7 (01) :59-63

[4] Neuroleptic malignant syndrome following administration of risperidone and lithium [J].

Bourgeois, JA ;

Kahn, DR .

JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2003, 23 (03) :315-317

[5]

CASANOVA B, 2000, NEUROPHARMACOLOGY, V19, P356

[6] Cortical myoclonus during lithium exposure [J].

Caviness, JN ;

Evidente, VGH .

ARCHIVES OF NEUROLOGY, 2003, 60 (03) :401-404

[7]

Emilien G, 1996, ACTA NEUROL BELG, V96, P281

[8]

Fallgatter AJ, 1997, NERVENARZT, V68, P586, DOI 10.1007/s001150050165

[9] ACQUIRED TRANSIENT CNS HYPERSENSITIVITY TO LITHIUM-THERAPY [J].

GHADIRIAN, AM ;

LEHMANN, HE .

CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE, 1980, 25 (08) :662-665

[10]

Goldman SA, 1996, PSYCHOPHARMACOL BULL, V32, P299

← 1 2 →